Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 10 2020
Historique:
received: 11 02 2020
accepted: 29 09 2020
entrez: 15 10 2020
pubmed: 16 10 2020
medline: 15 1 2021
Statut: epublish

Résumé

Analysis of large gene expression datasets from biopsies of cancer patients can identify co-expression signatures representing particular biomolecular events in cancer. Some of these signatures involve genomically co-localized genes resulting from the presence of copy number alterations (CNAs), for which analysis of the expression of the underlying genes provides valuable information about their combined role as oncogenes or tumor suppressor genes. Here we focus on the discovery and interpretation of such signatures that are present in multiple cancer types due to driver amplifications and deletions in particular regions of the genome after doing a comprehensive analysis combining both gene expression and CNA data from The Cancer Genome Atlas.

Identifiants

pubmed: 33057153
doi: 10.1038/s41598-020-74276-6
pii: 10.1038/s41598-020-74276-6
pmc: PMC7566486
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17199

Références

Oncogene. 2007 Oct 11;26(46):6593-603
pubmed: 17452972
J Korean Med Sci. 2007 Sep;22 Suppl:S47-51
pubmed: 17923754
Nucleic Acids Res. 2015 Jan;43(Database issue):D1133-9
pubmed: 25326331
Nature. 2020 Feb;578(7793):129-136
pubmed: 32025019
Cell Death Dis. 2018 Aug 1;9(8):825
pubmed: 30068946
Nat Genet. 2013 Oct;45(10):1134-40
pubmed: 24071852
Hepatology. 2015 Apr;61(4):1284-94
pubmed: 25503676
Gynecol Oncol. 2017 Mar;144(3):613-620
pubmed: 28073598
Cell. 2010 Dec 10;143(6):1005-17
pubmed: 21129771
Nat Commun. 2014;5:3231
pubmed: 24488081
Sci Rep. 2017 Apr 4;7(1):641
pubmed: 28377632
Cancer Res. 2003 Nov 1;63(21):7068-75
pubmed: 14612497
World J Gastroenterol. 2007 Jun 7;13(21):2986-91
pubmed: 17589952
Int J Oncol. 2019 Mar;54(3):1001-1009
pubmed: 30628658
Nat Rev Neurol. 2012 Oct;8(10):539-40
pubmed: 22986433
Cell Death Differ. 2010 Sep;17(9):1420-34
pubmed: 20203691
Sci Rep. 2017 Feb 07;7:42060
pubmed: 28169357
Exp Cell Res. 2018 Feb 1;363(1):39-47
pubmed: 29307786
Int J Cancer. 2005 May 1;114(5):720-9
pubmed: 15609312
Br J Cancer. 2010 Jul 27;103(3):401-10
pubmed: 20628393
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
BMC Bioinformatics. 2004 Aug 31;5:118
pubmed: 15339346
Genome Biol. 2011;12(4):R41
pubmed: 21527027
Blood. 2012 Apr 5;119(14):3285-94
pubmed: 22343915
Clin Cancer Res. 2005 Dec 1;11(23):8265-72
pubmed: 16322284
Cancer Cell. 2018 Apr 9;33(4):676-689.e3
pubmed: 29622463
Genome Biol. 2007;8(10):R215
pubmed: 17925008
Cell. 2002 Apr;109 Suppl:S21-33
pubmed: 11983150
Am J Cancer Res. 2017 Sep 01;7(9):1804-1819
pubmed: 28979805
BMC Cancer. 2016 Nov 22;16(1):911
pubmed: 27871313
Genes Chromosomes Cancer. 2010 Jun;49(6):569-75
pubmed: 20232484
Mol Oncol. 2018 Mar;12(3):391-405
pubmed: 29360267
Cancer Res. 2015 Feb 15;75(4):624-7
pubmed: 25634214
Oncol Rep. 2018 Oct;40(4):2343-2352
pubmed: 30066880
Leuk Lymphoma. 2017 May;58(5):1207-1218
pubmed: 28185526
Cancer Res. 2018 Apr 15;78(8):1914-1922
pubmed: 29431636
PLoS Genet. 2017 Sep 7;13(9):e1006994
pubmed: 28880866
Cancer Res. 2008 Nov 15;68(22):9532-40
pubmed: 19010930
Sci Rep. 2020 May 20;10(1):8341
pubmed: 32433524
Nat Commun. 2017 Dec 19;8(1):2187
pubmed: 29259170
Biochim Biophys Acta. 2016 Jun;1862(6):1172-81
pubmed: 27039663
Oncogenesis. 2019 Apr 15;8(5):29
pubmed: 30988276
Blood. 2002 Jun 1;99(11):4116-21
pubmed: 12010815
BMC Bioinformatics. 2017 Jul 11;18(1):333
pubmed: 28697800
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5459-64
pubmed: 18391219
Oncotarget. 2017 Nov 27;8(65):109247-109257
pubmed: 29312605
Oncogene. 1998 Jul 16;17(2):237-40
pubmed: 9674708
Biomed Pharmacother. 2019 Nov;119:109414
pubmed: 31518875
Genes Chromosomes Cancer. 2017 Aug;56(8):589-597
pubmed: 28316110
Sci Rep. 2017 Aug 17;7(1):8617
pubmed: 28819158
Nature. 2010 Feb 18;463(7283):899-905
pubmed: 20164920
PLoS Comput Biol. 2013;9(2):e1002920
pubmed: 23468608
Nat Genet. 2015 Feb;47(2):115-25
pubmed: 25581432
Am J Hum Genet. 1998 Aug;63(2):625-37
pubmed: 9683604
Mol Med Rep. 2013 Nov;8(5):1373-8
pubmed: 24045431
Cell Mol Life Sci. 2019 Nov;76(21):4275-4289
pubmed: 31309249
J Pathol. 2017 Jan;241(1):67-79
pubmed: 27741356
BMC Med Genet. 2019 Nov 9;20(1):175
pubmed: 31706287
PLoS One. 2013 Jun 18;8(6):e66196
pubmed: 23823315
Oncogenesis. 2019 Jan 9;8(1):4
pubmed: 30631037
Br J Cancer. 2006 Nov 20;95(10):1439-47
pubmed: 17060936
Nat Rev Cancer. 2013 Jun;13(6):378
pubmed: 23640208
BMC Cancer. 2018 Mar 12;18(1):275
pubmed: 29530001
Sci Transl Med. 2013 Apr 17;5(181):181ra50
pubmed: 23596202
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Commun. 2014 Nov 14;5:5384
pubmed: 25395170
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2850-6
pubmed: 25249324
Cancer Res. 2008 Apr 15;68(8):2551-6
pubmed: 18413720
Cell Res. 2017 Mar;27(3):315-328
pubmed: 28106072
J Transl Med. 2015 May 12;13:153
pubmed: 25963978
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):E2205-14
pubmed: 22778409
Nature. 2014 Dec 4;516(7529):116-20
pubmed: 25470042
BMC Cancer. 2015 Mar 14;15:126
pubmed: 25879652
Carcinogenesis. 2019 May 14;40(3):474-486
pubmed: 30371740
Clin Cancer Res. 2003 Jun;9(6):1995-2004
pubmed: 12796361
F1000Res. 2018 Aug 3;7:1189
pubmed: 30271587
PLoS One. 2016 Nov 30;11(11):e0167374
pubmed: 27902773
Breast Cancer Res. 2014 Nov 22;16(6):466
pubmed: 25416589
Genome Biol. 2016 Jun 10;17(1):125
pubmed: 27287018
Int J Mol Sci. 2013 Feb 01;14(2):3094-109
pubmed: 23377018
Nat Commun. 2015 Jun 17;6:7351
pubmed: 26081979
Onco Targets Ther. 2018 Nov 05;11:7805-7820
pubmed: 30464528
Cell Metab. 2006 Jul;4(1):1-3
pubmed: 16814724
Mod Pathol. 2013 Jul;26(7):975-83
pubmed: 23370768
Sci Rep. 2017 Nov 7;7(1):14621
pubmed: 29116104
DNA Cell Biol. 2014 Feb;33(2):73-8
pubmed: 24303950
Carcinogenesis. 2014 Mar;35(3):670-82
pubmed: 24148822
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20007-12
pubmed: 18077431
Clin Cancer Res. 2013 Jun 1;19(11):2850-60
pubmed: 23575475
Genes (Basel). 2020 Mar 15;11(3):
pubmed: 32183428

Auteurs

Gaojianyong Wang (G)

Department of Electrical Engineering, Columbia University, New York, NY, 10027, USA.

Dimitris Anastassiou (D)

Department of Electrical Engineering, Columbia University, New York, NY, 10027, USA. d.anastassiou@columbia.edu.
Department of Systems Biology, Columbia University, New York, NY, 10032, USA. d.anastassiou@columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH